SCHEMBL17876009

SCHEMBL17876009

O=S1(=O)Cc2ccc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2-c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 1/20 0.47
NTRK2 Q16620 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TDP2 O95551 3/20 0.42
NPC1 O15118 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
APAF1 O14727 1/20 0.42
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
XBP1 P17861 1/20 0.42
PTBP1 P26599 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
GALK1 P51570 1/20 0.42
BLM P54132 1/20 0.42
SMAD3 P84022 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875959 0.94 TDP2 (0.45) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17876011 0.89 CYP19A1 (0.43) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17876010 0.87 TDP2 (0.52) TYRO3NTRK2CLK4DYRK1BTDP2
SCHEMBL17876013 0.85 MEN1 (0.43) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17875961 0.85 CYP19A1 (0.39) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17875975 0.85 CYP19A1 (0.39) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17876003 0.84 PLA2G2A (0.44) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17875999 0.84 MMP12 (0.41) TYRO3NTRK2CLK4DYRK1BMEN1
SCHEMBL17875957 0.83 TDP2 (0.51) TDP2CYP3A4
SCHEMBL17876012 0.81 TDP2 (0.52) TDP2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 TYRO3 4480/4885NTRK2 4745/4885CLK4 2308/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 TYRO3 4480/4885NTRK2 4745/4885CLK4 2308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.